DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 10 · Volume 88 · 2002 DOI: 10.1055/s-008-36096

Commentary

541
Aledort, Louis M.: Can Costs of Hemophilia Products be Curtailed? Not as we Do Business Today!
542
Kletter, Stephen D.; Rankin, Peter J.: Cost Trends in the Treatment for Hemophilia: Another View

In Focus

545
Rogoff, Edward G.; Guirguis, Hany S.; Lipton, Richard A.; Seremetis, Stephanie V.; DiMichele, Donna M.; Agnew, George M.; Karpatkin, Margaret; Barish, Robert J.; Jones, Robert L.; Bianco, Celso; Knothe, Barbara D.; Lee, Myung-Soo: The Upward Spiral of Drug Costs: A Time Series Analysis of Drugs Used in the Treatment of Hemophilia

Review Article

554
Young, James L.; Libby, Peter; Schönbeck, Uwe: Cytokines in the Pathogenesis of Atherosclerosis
568
Reding, Mark T.; Lei, Sijin; Lei, Howard; Green, Daid; Gill, Joan; Conti-Fine, Bianca M.: Distribution of Th1- and Th2-induced Anti-factor VIII IgG Subclasses in Congenital and Acquired Hemophilia Patients
576
Al Dieri, Raed; Peyvandi, Flora; Santagostino, Elena; Giansily, Muriel; Mannucci, Pier Mannuccio; Schved, Jean François; Béguin, Suzette; Hemker, H. Coenraad: The Thrombogram in Rare Inherited Coagulation Disorders: Its Relation to Clinical Bleeding
583
Tripodi, Armando; Chantarangkul, Veena; Clerici, Marigrazia; Mannucci, Pier Mannuccio: Laboratory Diagnosis of Lupus Anticoagulants for Patients on Oral Anticoagulant Treatment
587
Oger, Emmanuel; Lacut, Karine; Le Gal, Grégoire; Van Dreden, Patrick; Bressollette, Luc; Scarabin, Pierre-Yves; Leroyer, Christophe; Mottier, Dominique: Is APC Resistance a Risk Factor for Venous Thromboembolism in Patients over 70 Years?
592
Oger, Emmanuel; Bressollette, Luc; Nonent, Michel; Lacut, Karine; Guias, Bruno; Couturaud, Francis; Leroyer, Christophe; Mottier, Dominique: High Prevalence of Asymptomatic Deep Vein Thrombosis on Admission in a Medical Unit among Elderly Patients
598
Rick, Margaret E.; Moll, Stephan; Taylor, Mark A.; Krizek, Dennis M.; White, Gilbert C.; Aronson, David L.: Clinical Use of a Rapid Collagen Binding Assay for von Willebrand Factor Cleaving Protease in Patients with Thrombotic Thrombocytopenic Purpura
605
Post, M. S.; van der Mooren, M. J.; Stehouwer, C. D. A.; van Baal, W. M.; Mijatovic, V.; Schalkwijk, C. G.; Kenemans, P.: Effects of Transdermal and Oral Oestrogen Replacement Therapy on C-Reactive Protein Levels in Postmenopausal Women: A Randomised, Placebo-Controlled Trial
611
Rao, Veena S.; Kini, R. Manjunatha: Pseutarin C, a Prothrombin Activator from Pseudonaja textilis Venom: Its Structural and Functional Similarity to Mammalian Coagulation Factor Xa-Va Complex
620
Izumi, Tomonori; Pound, Mary L.; Su, Zuowei; Iverson, G. Michael; Ortel, Thomas L.: Anti-β2-glycoprotein I Antibody-mediated Inhibition of Activated Protein C Requires Binding of β2-glycoprotein I to Phospholipids
627
Moons, Arno H. M.; Peters, Ron J. G.; Cate, Hugoten; Bauer, Kenneth A.; Vlasuk, George P.; Büller, Harry R.; Levi, Marcel: Recombinant Nematode Anticoagulant Protein c2, a Novel Inhibitor of Tissue Factor-Factor VIIa Activity, Abrogates Endotoxin-Induced Coagulation in Chimpanzees
632
Lind, Bent; Gedde-Dahl, Tobias; Tjønnfjord, Geir; Villoutreix, Bruno O.; Brosstad, Frank: Protein C Deficiency caused by Homozygosity for a Novel PROC D180G Mutation – in vitro Expression and Structural Analysis of the Mutation
639
Montes, Ramón; Rodríguez-Whilhelmi, Pablo; Hurtado, Verónica; Matsukawa, Akihiro; Montes, Marta; Hermida, José; Rocha, Eduardo: The Endotoxin-induced Plasminogen Activator Inhibitor-1 Increase in Rabbits Is Not Tumor Necrosis Factor-α Dependent and Can Occur in the Absence of Interleukin-1β
644
Antovic, J.P.; Hamad, R. Rafik; Antovic, A.; Blombäck, M.; Bremme, K.: Does Thrombin Activatable Fibrinolysis Inhibitor (TAFI) Contribute to Impairment of Fibrinolysis in Patients with Preeclampsia and/or Intrauterine Fetal Growth Retardation?
648
Elton, Catherine M.; Smethurst, Peter A.; Eggleton, Paul; Farndalerd, Rich W.: Physical and Functional Interaction Between Cell-Surface Calreticulin and the Collagen Receptors Integrin α2β1 and Glycoprotein VI in Human Platelets
655
Milet-Marsal, Sandrine; Breillat, Christelle; Peyruchaud, Olivier; Nurden, Paquita; Combrié, Robert; Nurden, Alan T.; Bourre, François: Analysis of the Amino Acid Requirement for a Normal αIIbβ3 Maturation at αIIbGlu324 Commonly Mutated in Glanzmann Thrombasthenia
663
Asakura, Hidesaku; Okudaira, Mariko; Yoshida, Tomotaka; Ontachi, Yasuo; Yamazaki, Masahide; Morishita, Eriko; Miyamoto, Ken-ichi; Nakao, Shinji: Induction of Vasoactive Substances Differs in LPS-Induced and TF-Induced DIC Models in Rats
668
Waissbluth, Alvaro; Ghigliotti, Giorgio; Abendschein, Dana R.; Eisenberg, Paul R.; Schwartz, David: Aurintricarboxylic Acid Attenuates Intimal Thickening after Balloon Injury of the Rabbit Aorta
673
Li, Chester Q.; Dong, Jing-fei; López, José A.: The Mucin-like Macroglycopeptide Region of Glycoprotein Ibα is Required for Cell Adhesion to Immobilized von Willebrand Factor (VWF) Under Flow but not for Static VWF Binding
678
Fusté, Berta; Serradell, Mireia; Escolar, Ginés; Cases, Aleix; Mazzara, Roberto; Castillo, Ricardo; Ordinas, Antonio; Díaz-Ricart, Maribel: Erythropoietin Triggers a Signaling Pathway in Endothelial Cells and Increases the Thrombogenicity of their Extracellular Matrices In Vitro
700
Baglin, Trevor; Greaves, Mike: Rebuttal: Is a Nihilistic Approach to Thrombophilia Screening Justified?

Letters to the Editor

686
Loynes, James T.; Zacharski, Leo R.; Rigas, James R.: Regression of Metastatic Non-Small Cell Lung Cancer with Low Molecular Weight Heparin
687
Leger, P.; Cambus, J. P.; Herault, J. P.; Herbert, J. M.; Boneu, B.: Anti-Thrombotic Effect of a Synthetic Heparin Mimetic in an Arterial Model of Thrombosis in Rats: Comparison with Unfractionated Heparin and Nadroparin
688
Gatica, Antonio; Panes, Olga; Tagle, Rodrigo; Pereira, Jaime; Mezzano, Diego: High Plasma Levels of Lipoprotein(a) in Uremic Patients are Related to Markers of Inflammation, and to Activated, not Impaired, Fibrinolysis
690
Tripodi, Armando; Peyvandi, Flora; Chantarangkul, Veena; Menegatti, Marzia; Mannucci, Pier Mannuccio: Relatively Poor Performance of Clinical Laboratories for DNA Analyses in the Detection of Two Thrombophilic Mutations – A Cause for Concern
691
Tamim, Hala; Finan, Ramzi R.; Almawi, Wassim Y.: Prevalence of Two Thrombophilia Predisposing Mutations: Factor V G1691A (R506Q; Leiden) and Prothrombin G20210A, among Healthy Lebanese
693
Ermis, Cengiz; Tsai, Micheal Y.; Hanson, Naomi Q.; Akar, Nejat; Aras, Ömer: Angiotensin I Converting Enzyme, Angiotensin II Type 1 Receptor and Angiotensinogen Polymorphisms and Early Myocardial Infarction in Turkish Population
694
Li, Yi-Heng; Chen, Jyh-Hong; Guo, How-Ran; Tsai, Wei-Chuan; Chao, Ting-Hsing: Genetic Risk Factors Associated with the Prognosis of Myocardial Infarction in Young Patients
697
Haselbauer, Andrea; Haberbosch, Werner; Tillmanns, Harald; Gardemann, Andreas: The Impact of the PAI-1 A(-844)G Promoter Polymorphism on the Risk and Extent of Coronary Heart Disease
698
Guillet, B.; Pinganaud, C.; Proulle, V.; Dreyfus, M.; Lambert, T.: Myocardial Infarction Occurring in a Case of Acquired Haemophilia During the Treatment Course with Recombinant Activated Factor VII
700
Shanbrom, Edward: Is the Poor Recovery of Commercial Recombinant Factors VIII and IX caused by Damage from Monoclonal Antibody Purification?
702
Perrier, Arnaud; Bounameaux, Henri: A Rebuttal: Withholding Anticoagulation in Patients with Suspected Pulmonary Embolism and a Low Probability Ventilation Perfusion Scan: An Unacceptable Risk